Related Experiment Video
Updated: Dec 25, 2025
09:23
Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
Published on: March 10, 2023
4.7K
Intensive care for human hearts in pluripotent stem cell models
Pelin Golforoush1, Michael D Schneider1
1National Heart and Lung Institute, Imperial College London, London, W12 0NN UK.
NPJ Regenerative Medicine
|March 21, 2020
Summary
Human stem cell models offer predictive preclinical tools for cardiac drug discovery, overcoming limitations of traditional models and reducing clinical trial failures. These models advance safety pharmacology and target validation for heart disease therapies.
Area of Science:
- Biomedical Science
- Cardiovascular Research
- Stem Cell Technology
Background:
- Drug discovery for cardiac conditions faces challenges due to a lack of predictive human preclinical models.
- This deficit contributes to high rates of clinical trial failures, even with promising non-human study results.
Purpose of the Study:
- To review the impact and applications of human pluripotent stem cell-derived models in cardiac drug discovery.
- To discuss current methodologies, disease models, and future prospects in this research area.
Main Methods:
- Review of existing literature on human pluripotent stem cell models in cardiac research.
- Analysis of applications including safety pharmacology, phenotypic screening, target validation, and high-throughput assays.
Main Results:
- Human cardiomyocytes derived from pluripotent stem cells are increasingly utilized in cardiac drug discovery.
- These models facilitate various stages of drug development, from early screening to target validation.
Conclusions:
- Human pluripotent stem cell models represent a significant advancement in cardiac drug discovery, offering improved predictive power.
- Further development and application of these models hold promise for reducing clinical trial attrition and accelerating the development of novel cardiovascular therapies.
